Theranostics · 2019 · 66 citations · 44 references
MedicineOncologyPathologyDiagnostic PathologyMolecular DiagnosticsMolecular PathologyCancer BiomarkersCancer Molecular DiagnosticsPancreatic CancerPancreatic DiseasesPancreatic PathologyTumor MarkersBiological PrognosisBiomarkersBlood-based BiomarkersCancer Antigen 19-9Curative TherapyEarly DiagnosisEarly Stage Disease DetectionLogistic Regression
These data establish the combination of CA19-9, THBS2 and cfDNA as a composite liquid biomarker for non-invasive diagnosis of early-stage PDAC.
44
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary et al. · Science Translational Medicine · 2014 · 5.1K citations · Full text
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Sónia A. Melo, Linda B. Luecke, Christoph Kahlert et al. · Nature · 2015 · 2.9K citations · Full text
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang et al. · Science · 2018 · 2.8K citations
Medicine, Oncology, Cancer Screening +16
Circulating mutant DNA to assess tumor dynamics
Frank Diehl, Kerstin Schmidt, Michael A. Choti et al. · Nature Medicine · 2008 · 2.7K citations · Full text
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell, Marina Pajic, Ann‐Marie Patch et al. · Nature · 2015 · 2.7K citations · Full text